Variation in Pediatric Procedural Sedations Across Children's Hospital Emergency Departments

Andrew F Miller1,2, Michael C Monuteaux3, Florence T Bourgeois3,2

  • 1Division of Emergency Medicine, Boston Children's Hospital, Boston, Massachusetts; and andrew.miller@childrens.harvard.edu.

Hospital Pediatrics
|December 14, 2017
PubMed

Insights

Pediatric procedural sedation use varied significantly across children's hospitals. Medication trends shifted, with increased use of fentanyl and midazolam, and decreased ketamine use. This highlights potential overuse or underuse in some facilities.

Area of Science:

  • Pediatric Emergency Medicine
  • Pharmacology
  • Health Services Research

Background:

  • Procedural sedation is common in pediatric emergency departments (EDs).
  • Understanding trends and variations in sedation use is crucial for optimizing patient care and resource allocation.
  • Existing data on sedation practices across diverse pediatric EDs is limited.

Purpose of the Study:

  • To describe trends in pediatric procedural sedation use over time (2009-2014).
  • To determine variations in procedural sedation utilization across children's hospital emergency departments.
  • To identify shifts in specific sedative medication preferences.

Main Methods:

  • Analysis of emergency department data from 35 children's hospitals (2009-2014).
  • Inclusion of patients under 19 years old receiving sedation and discharged.
  • Exclusion of patients with chronic comorbidities or undergoing intubation.
  • Descriptive statistics with appropriate weighting to assess frequency, trends, and inter-hospital variation.

Main Results:

  • Approximately 7.9% of eligible patients (99,951 out of 1,448,011) received procedural sedation.
  • In 2014, ketamine was most common (73.7%), followed by fentanyl/midazolam (15.9%), ketofol (7.3%), and propofol (2.7%).
  • Fentanyl/midazolam use increased, while ketamine and other agents decreased over time.
  • Significant variation in sedation rates observed across hospitals (0.2% to 32.0% in 2014).
  • Dislocation treatment showed the largest variation in sedation use (2% to 35%).

Conclusions:

  • Substantial variability exists in procedural sedation practices among pediatric emergency departments.
  • These variations suggest potential inconsistencies in sedation administration, possibly indicating overuse or underuse in certain settings.
  • Further research is needed to establish evidence-based guidelines and standardize sedation practices in pediatric EDs.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
782
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.8K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
337
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
335
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
718